Literature DB >> 10587434

Structural correlates for enhanced stability in the E2 DNA-binding domain from bovine papillomavirus.

S Veeraraghavan1, C C Mello, E J Androphy, J D Baleja.   

Abstract

Papillomaviral E2 proteins participate in viral DNA replication and transcriptional regulation. We have solved the solution structure of the DNA-binding domain of the E2 protein from bovine papillomavirus (BPV-1). The structure calculation used 2222 distance and 158 dihedral angle restraints for the homodimer (202 residues in total), which were derived from homonuclear and heteronuclear multidimensional nuclear magnetic resonance (NMR) spectroscopic data. The root-mean-square deviation for structured regions of the monomer when superimposed to the average is 0.73 +/- 0.10 A for backbone atoms and 1.42 +/- 0.16 A for heavy atoms. The 101 residue construct used in this study (residues 310-410) is about 4.5 kcal/mol more stable than a minimal domain comprising the C-terminal 85 amino acid residues (residues 326-410). The structure of the core domain contained within BPV-1 E2 is similar to the corresponding regions of other papilloma viral E2 proteins. Here, however, the extra N-terminal 16 residues form a flap that covers a cavity at the dimer interface and play a role in DNA binding. Interactions between residues in the N-terminal extension and the core domain correlate with the greater stability of the longer form of the protein relative to the minimal domain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587434     DOI: 10.1021/bi991633x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers.

Authors:  Reet Kurg; Helena Tekkel; Aare Abroi; Mart Ustav
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  Solution structure of the HPV-16 E2 DNA binding domain, a transcriptional regulator with a dimeric beta-barrel fold.

Authors:  Alejandro D Nadra; Tommaso Eliseo; Yu-Keung Mok; C L Almeida; Mark Bycroft; Maurizio Paci; Gonzalo de Prat-Gay; Daniel O Cicero
Journal:  J Biomol NMR       Date:  2004-10       Impact factor: 2.835

3.  Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain.

Authors:  Asokan Anbanandam; Diana C Albarado; Catherine T Nguyen; Georg Halder; Xiaolian Gao; Sudha Veeraraghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

4.  MD simulations of papillomavirus DNA-E2 protein complexes hints at a protein structural code for DNA deformation.

Authors:  M Falconi; F Oteri; T Eliseo; D O Cicero; A Desideri
Journal:  Biophys J       Date:  2008-05-16       Impact factor: 4.033

5.  Design and characterization of an enhanced repressor of human papillomavirus E2 protein.

Authors:  Kakoli Bose; Gretchen Meinke; Andrew Bohm; James D Baleja
Journal:  FASEB J       Date:  2011-04-11       Impact factor: 5.191

6.  Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication.

Authors:  C D Newhouse; S J Silverstein
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Protein flexibility directs DNA recognition by the papillomavirus E2 proteins.

Authors:  Craig Brown; Karen Campos-León; Madeleine Strickland; Christopher Williams; Victoria Fairweather; R Leo Brady; Matthew P Crump; Kevin Gaston
Journal:  Nucleic Acids Res       Date:  2010-12-03       Impact factor: 16.971

8.  The recognition of local DNA conformation by the human papillomavirus type 6 E2 protein.

Authors:  Elizabeth Hooley; Victoria Fairweather; Anthony R Clarke; Kevin Gaston; R Leo Brady
Journal:  Nucleic Acids Res       Date:  2006-08-12       Impact factor: 16.971

Review 9.  Evolutionary and biophysical relationships among the papillomavirus E2 proteins.

Authors:  Dukagjin M Blakaj; Narcis Fernandez-Fuentes; Zigui Chen; Rashmi Hegde; Andras Fiser; Robert D Burk; Michael Brenowitz
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.